A pilot study to assess the effect of beta blockade on exercise capacity and BNP levels in patients with predominantly diastolic heart failure

Authors
Category Primary study
Registry of TrialsISRCTN registry
Year 2006
INTERVENTION: 1. Bisoprolol (1.25 mg daily) 2. Placebo CONDITION: Cardiovascular: Heart failure ; Circulatory System ; Heart failure PRIMARY OUTCOME: The change from baseline in plasma BNP measurements SECONDARY OUTCOME: Not provided at time of registration INCLUSION CRITERIA: A total of 40 patients with evidence or history of clinical heart failure, ejection fraction of >45% and raised plasma BNP levels.
Epistemonikos ID: c173cc6e2181f0dd928034016327309bd647a3b5
First added on: Aug 21, 2024